SOAT1 and neoplasm: STAT1 is known to be activated by signaling from INFs, and advanced studies on the development of JAK/STAT inhibitors have found that expression of the STAT1 pathway confers cellular resistance to DNA-damaging agents and supports tumor growth [20].